| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3334901 | Transfusion and Apheresis Science | 2015 | 5 Pages |
Abstract
Our overall red cell alloimmunisation rate was 2.5%. Alloimmunisation rate among HSCT transplant patients was 1.6% as compared to the 2.4% in patients with solid organ malignancies. Keeping in view the low alloimmunisation rate, the justification of repeating antibody screening 72 hours post transfusion in this category of patients needs to be re-assessed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Supriya Dhar, Sabita Basu,